Dergiler / Pediatric Urology Case Reports / 2019 / Cilt: 6 - Sayı: 4

Extensive pelvic lymphatic malformations presenting with hematospermia: A case report

Sayfa
83–87
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Pelvic lymphatic malformations should be considered as a possible etiology for otherwise unexplained bleeding episodes in the adolescent genitourinary system.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Lymphatic malformations are rare vascular abnormalities that usually occur in the head and neck but can occur elsewhere in the body.
📊
Temel Bulgular & Veri:Here, we present an unusual case of a 14-year-old male who presents with hematospermia, hematochezia, and hematuria.
💡
Sonuç & Katkı:Pelvic lymphatic malformations should be considered as a possible etiology for otherwise unexplained bleeding episodes in the adolescent genitourinary system.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Lymphatic malformations are rare vascular abnormalities that usually occur in the head and neck but can occur elsewhere in the body. Here, we present an unusual case of a 14-year-old male who presents with hematospermia, hematochezia, and hematuria. Following work-up which included urinalysis, ultrasound, and magnetic resonance imaging (MRI), the patient was diagnosed with pelvic lymphatic malformations (LMs), including a perirectal lesion and a lesion involving the right spermatic cord. He was started on sirolimus therapy, which resolved the hematospermia and hematuria, and decreased the frequency of the hematochezia. However, the hematochezia did not resolve completely and the patient wished to discontinue sirolimus. The decision was made to pursue doxycycline sclerotherapy for the perirectal lesion. The hematochezia resolved for two weeks following sclerotherapy, but resumed soon thereafter. Options to further manage the patient’s symptoms include re-starting sirolimus or repeating doxycycline sclerotherapy. To our knowledge, this is the first report of a lymphatic malformation presenting with hematospermia. Pelvic lymphatic malformations should be considered as a possible etiology for otherwise unexplained bleeding episodes in the adolescent genitourinary system.

🔖

Bu Makaleye Atıf Yap

NETHALA, D., MORGENSTERN, B. A., ANDREA, V. D., FİNE, R. (2019). Extensive pelvic lymphatic malformations presenting with hematospermia: A case report. Pediatric Urology Case Reports, Cilt: 6 - Sayı: 4, 83–87. https://ajindex.com/articles/285571

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope. 2001;111(11 Pt 1):1929-37. [2]Elluru RG,. Balakrishnan K, Padua H.M. Lymphatic malformations: diagnosis and management. Semin Pediatr Surg. 2014; 23(4): 178-85. [3]Demir Y, Latifoğlu O, Yenidünya S, Atabay K. Extensive lymphatic malformation of penis and scrotum. Urology. 2001;58(1):106. [4]Benazzou S, Boulaadas M Essakalli L. Giant pediatric cervicofacial lymphatic malformations. J Craniofac Surg. 2013; 24(4): 1307-9. [5]Gilony D, Schwartz M, Shpitzer T, Feinmesser R, Kornreich L, Raveh E. Treatment of lymphatic malformations: a more conservative approach. J Pediatr Surg. 2012;47(10):1837-42. [6]Vignot S, Faivre S, Aguirre D, Raymond E. mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol. 2005;16(4):525-37. [7]Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(4):1048- 54.e1-5. [8]Strychowsky JE, Rahbar R, O'Hare MJ, Irace AL, Padua H, Trenor CC 3rd. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope. 2018;128(1):269-76. [9]Khunger, N. Lymphatic Malformations: Current Status. J Cutan Aesthet Surg. 2010; 3(3): 137-38.